Funding for this research was provided by:
Japan Agency for Medical Research and Development (18he1402003)
Received: 26 August 2021
Accepted: 1 April 2022
First Online: 14 April 2022
: The study was conducted in accordance with the Helsinki Declaration and approved by the institutional review board of Oita University Hospital. All participants provided written informed consent before the study.
: Not applicable.
: Dr. Kimura received a grant from the Japan Society for the Promotion of Science and received honoraria from Takeda Pharmaceutical, Janssen Pharmaceutical, Daiichi Sankyo, Eisai, Sumitomo Dainippon Pharma, FUJIFILM Toyama, Kyowa Kirin, Otsuka Pharmaceutical, and Tsumura outside the submitted work. No other disclosures were reported.